Adamas Pharma
(ADMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,214 | -16,648 | -105,186 | -82,111 | -54,529 |
| Depreciation Amortization | 313 | 129 | -5 | 958 | 692 |
| Accounts receivable | -838 | 23 | -259 | -25 | -900 |
| Accounts payable and accrued liabilities | -4,436 | -3,298 | 398 | 178 | -253 |
| Other Working Capital | -8,343 | -4,487 | -5,173 | -3,411 | -3,295 |
| Other Operating Activity | 10,990 | 6,968 | 29,446 | 21,945 | 14,478 |
| Operating Cash Flow | $-29,528 | $-17,313 | $-80,779 | $-62,466 | $-43,807 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,039 | -2,962 | 88,881 | 77,105 | 49,343 |
| PPE Investments | N/A | N/A | -18 | -18 | -18 |
| Sale Of Investment | 17,066 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-5,973 | $-2,962 | $88,863 | $77,087 | $49,325 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,650 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 42 | 42 | 310 | 298 | 165 |
| Other Financing Activity | -2,427 | 0 | 775 | 449 | 449 |
| Financing Cash Flow | $265 | $42 | $1,085 | $747 | $614 |
| Beginning Cash Position | 65,774 | 65,774 | 56,605 | 56,605 | 56,605 |
| End Cash Position | 30,538 | 45,541 | 65,774 | 71,973 | 62,737 |
| Net Cash Flow | $-35,236 | $-20,233 | $9,169 | $15,368 | $6,132 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,528 | -17,313 | -80,779 | -62,466 | -43,807 |
| Capital Expenditure | 0 | N/A | -18 | -18 | -18 |
| Free Cash Flow | -29,528 | -17,313 | -80,797 | -62,484 | -43,825 |